Scinai Immunotherapeutics (SCNI) Capital Expenditures (2018 - 2026)
Scinai Immunotherapeutics (SCNI) posted Capital Expenditures of -$3000.0 for Q1 2026, little changed sequentially from -$3000.0 in Q2 2025, and up 66.67% YoY from -$1800.0 in Q1 2025.
Scinai Immunotherapeutics (SCNI) Capital Expenditures (2018 - 2026) Analysis & Trends
Scinai Immunotherapeutics has reported Capital Expenditures for 9 years, with the latest figure at -$3000.0 in Q1 2026.
- Quarterly Capital Expenditures rose 66.67% year-over-year to -$3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9000.0 (up 80.0% YoY) and the FY2025 annual result came in at $24000.0, up 100.0% from the prior year.
- Capital Expenditures held at -$3000.0 in Q1 2026 per SCNI's latest filing, from -$3000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $1.4 million in Q4 2022 and troughed at -$377000.0 in Q2 2023.
- A 5-year average of $162200.0 and a median of -$4000.0 in 2024 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 7542.86% in 2022, down 1900.0% in 2022.
- Over 5 years, Capital Expenditures stood at $1.4 million in 2022, then retreated by 25.82% to $1.0 million in 2023, then sank by 97.69% to $24000.0 in 2024, then sank by 112.5% to -$3000.0 in 2025, then changed by 0.0% to -$3000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered -$3000.0, -$3000.0, and -$9000.0 for Q1 2026, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Scinai Immunotherapeutics | 11.72 Mn | -3.10 Bn | -1.12 Mn | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Jun 30, 2024 | -6,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Mar 31, 2024 | -2,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | -20,000.00 |
| Sep 30, 2023 | -20,000.00 |
| Jun 30, 2023 | -377,000.00 |
| Jun 30, 2023 | -377,000.00 |